254 related articles for article (PubMed ID: 33918274)
21. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
22. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
[TBL] [Abstract][Full Text] [Related]
23. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
24. miRNA expression is highly sensitive to a drug therapy in Parkinson's disease.
Alieva AKh; Filatova EV; Karabanov AV; Illarioshkin SN; Limborska SA; Shadrina MI; Slominsky PA
Parkinsonism Relat Disord; 2015 Jan; 21(1):72-4. PubMed ID: 25465742
[TBL] [Abstract][Full Text] [Related]
25. Serum microRNA expression levels in Turkish patients with Parkinson's disease.
Ozdilek B; Demircan B
Int J Neurosci; 2021 Dec; 131(12):1181-1189. PubMed ID: 32546033
[TBL] [Abstract][Full Text] [Related]
26. Combinatory microRNA serum signatures as classifiers of Parkinson's disease.
Patil KS; Basak I; Dalen I; Hoedt E; Lange J; Lunde KA; Liu Y; Tysnes OB; Forsgren L; Aarsland D; Neubert TA; Larsen JP; Alves G; Møller SG
Parkinsonism Relat Disord; 2019 Jul; 64():202-210. PubMed ID: 31003905
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
[TBL] [Abstract][Full Text] [Related]
28. Meta-analyses identify differentially expressed micrornas in Parkinson's disease.
Schulz J; Takousis P; Wohlers I; Itua IOG; Dobricic V; Rücker G; Binder H; Middleton L; Ioannidis JPA; Perneczky R; Bertram L; Lill CM
Ann Neurol; 2019 Jun; 85(6):835-851. PubMed ID: 30990912
[TBL] [Abstract][Full Text] [Related]
29. miR-486-3p Influences the Neurotoxicity of a-Synuclein by Targeting the SIRT2 Gene and the Polymorphisms at Target Sites Contributing to Parkinson's Disease.
Wang Y; Cai Y; Huang H; Chen X; Chen X; Chen X; Mai H; Li X; Zhao J; Yang J; Fan W; Tang P; Chen Y; Li K; Cui L
Cell Physiol Biochem; 2018; 51(6):2732-2745. PubMed ID: 30562735
[TBL] [Abstract][Full Text] [Related]
30. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.
Burgos K; Malenica I; Metpally R; Courtright A; Rakela B; Beach T; Shill H; Adler C; Sabbagh M; Villa S; Tembe W; Craig D; Van Keuren-Jensen K
PLoS One; 2014; 9(5):e94839. PubMed ID: 24797360
[TBL] [Abstract][Full Text] [Related]
31. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
32. microRNAs involved in Parkinson's disease: A systematic review.
da Silva FC; Iop RD; Vietta GG; Kair DA; Gutierres Filho PJ; de Alvarenga JG; da Silva R
Mol Med Rep; 2016 Nov; 14(5):4015-4022. PubMed ID: 27666518
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
Cao XY; Lu JM; Zhao ZQ; Li MC; Lu T; An XS; Xue LJ
Neurosci Lett; 2017 Mar; 644():94-99. PubMed ID: 28223160
[TBL] [Abstract][Full Text] [Related]
34. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
[TBL] [Abstract][Full Text] [Related]
35. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
[TBL] [Abstract][Full Text] [Related]
36. A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration.
Grassmann F; Schoenberger PG; Brandl C; Schick T; Hasler D; Meister G; Fleckenstein M; Lindner M; Helbig H; Fauser S; Weber BH
PLoS One; 2014; 9(9):e107461. PubMed ID: 25203061
[TBL] [Abstract][Full Text] [Related]
37. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
[TBL] [Abstract][Full Text] [Related]
38. Modified level of miR-376a is associated with Parkinson's disease.
Baghi M; Rostamian Delavar M; Yadegari E; Peymani M; Pozo D; Hossein Nasr-Esfahani M; Ghaedi K
J Cell Mol Med; 2020 Feb; 24(4):2622-2634. PubMed ID: 31930701
[TBL] [Abstract][Full Text] [Related]
39. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
[TBL] [Abstract][Full Text] [Related]
40. Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset.
Zhong D; Wu C; Xu D; Bai J; Wang Q; Zeng X
Biomed Res Int; 2021; 2021():6676107. PubMed ID: 34368354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
